Eletriptan (eletriptan)

Approved for RELPAX is indicated for the acute treatment of migraine with or without aura in adults.. Eletriptan binds with high affinity to 5-HT 1B , 5-HT 1D and 5-HT 1F receptors, has modest affinity for 5-HT 1A , 5-HT 1E , 5-HT 2B and 5-HT 7 receptors. Migraines are likely due to local cranial… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels,…

Loading full data from Know Your Drugs Institute…